André Marques Veras
About André Marques Veras
André Marques Veras is the Associate Director of Global Hematology FP&A at Bristol Myers Squibb and Head of Business Planning Europe at Oncopeptides AB, with over a decade of experience in financial planning and analysis within the pharmaceutical industry.
Current Roles
André Marques Veras is currently serving as the Associate Director, Global Hematology FP&A at Bristol Myers Squibb. Concurrently, he holds the position of Head of Business Planning Europe at Oncopeptides AB in Switzerland. In these roles, André focuses on financial planning and analysis, as well as strategic business planning within the pharmaceutical industry.
Prior Experience
André Marques Veras has accumulated extensive experience in the pharmaceutical and business sectors. He worked at Celgene in various capacities from 2014 to 2020 in Switzerland and Portugal, including roles such as Senior Manager F&BP Worldwide Markets and Sr. Business Analyst Portugal. Before his tenure at Celgene, André was a Finance Controller at DXC Technology from 2008 to 2014 and a Client Manager at Nestlé from 2006 to 2008.
Education and Expertise
André Marques Veras holds an MBA from ESMT Berlin and a degree in Business Management from Lisbon Accounting and Business School-ISCAL. With over a decade of experience in financial planning and analysis within the pharmaceutical industry, André specializes in developing short-term and long-term strategic plans. He also has robust expertise in analyzing diverse factors impacting the pharmaceutical sector.
Skills and Specializations
Known for his strong cross-cultural communication skills, André Marques Veras excels in developing long-lasting relationships with global stakeholders. He has a proven track record of mentoring and leading teams to achieve their full potential. His skills encompass both financial planning and analysis, as well as strategic business planning, particularly within the context of the pharmaceutical industry.